Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 7Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 7Lymphoid 6Dermatologic 2Sarcoma 1Other solid neoplasm 1

Conditions

Melanoma 2

Interventions

pembrolizumab 58Ipilimumab 53Cyclophosphamide 53Nivolumab 45aldesleukin 35Interleukin-2 26fludarabine phosphate 22fludarabine 21Vemurafenib 20Temozolomide 19Radiotherapy 19dabrafenib 15trametinib 12Radiosurgery 11CTLA-4 Antigen 11spartalizumab 10Filgrastim 10Dacarbazine 10cobimetinib 9binimetinib 9atezolizumab 9Biopsy 9poly ICLC 8Paclitaxel 8Antilymphocyte Serum 8encorafenib 7avelumab 7Rituximab 7Introns 7romidepsin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Vinblastine × Dermatologic × Clear all
NCT00505635 2020-09-24

Biochemotherapy With Temozolomide for Metastatic Melanoma

M.D. Anderson Cancer Center

Phase 2 Terminated
5 enrolled 5 charts
Dermatologic

Melanoma

NCT01542255 2019-01-15

Metronomic Therapy in Patients With Metastatic Melanoma

Dartmouth-Hitchcock Medical Center

Phase 2 Terminated
7 enrolled 4 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡